Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1980 Jan 12;122(1):37-38, 40-46.

Plasma lipoprotein levels and the prevalence of hyperlipoproteinemia in a Canadian working population

GJL Jones, D Hewitt, GJ Godin, WC Breckenridge, J Bird, MA Mishkel, G Steiner, JA Little
PMCID: PMC1801586  PMID: 7363194

Abstract

The lipids and lipoproteins — cholesterol (C), triglyceride (TG) and high-density, low-density, very-low-density and sinking pre-β-lipoprotein cholesterol (HDL-C, LDL-C, VLDL-C and SPB-C) — in plasma samples from 1620 fasting white adults and children from the Toronto—Hamilton area were analysed. The mean concentration of HDL-C was about 45 mg/dl in men and about 60 mg/dl in women, and the levels were constant throughout adult life in both sexes. Boys had higher mean HDL-C levels than men, but girls had lower mean HDL-C levels than women. Mean LDL-C levels, like total C levels, increased with age, from about 87 mg/dl in boys to 136 mg/dl in men, and from about 91 mg/dl in girls to 145 mg/dl in women. The mean levels of VLDL-C followed the TG patterns for age and sex, rising from about 7 mg/dl in boys to 26 mg/dl in men, and from about 11 mg/dl in girls to 19 mg/dl in women. SPB-C was detectable visually in 39% of the population and with the aid of densitometry in 54%; the levels were not related to age, sex or oral contraceptive use, and the median level was 3 mg/dl.

Prevalence estimates of hyperlipoproteinemia showed that type IV was the most common, and it was found more than three times as often in men as in women. This was in part due to the customary use of plasma TG cut-off points that do not reflect the large difference in TG levels between males and females. Type IIA hyperlipoproteinemia was found in about 2% of the adults and type IIb in a further 1%. Types I, III and V were all rare. The prevalence of types II and IV hyperlipoproteinemia was four times greater in women using oral contraceptives than in nonusers in the same age range.

Full text

PDF
37

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albers J. J., Cabana V. G., Warnick G. R., Hazzard W. R. Lp(a) lipoprotein: relationship to sinking pre-beta lipoprotein hyperlipoproteinemia, and apolipoprotein B. Metabolism. 1975 Sep;24(9):1047–1054. doi: 10.1016/0026-0495(75)90098-0. [DOI] [PubMed] [Google Scholar]
  2. Albers J. J., Hazzard W. R. Immunochemical quantification of human plasma Lp(a) lipoprotein. Lipids. 1974 Jan;9(1):15–26. doi: 10.1007/BF02533209. [DOI] [PubMed] [Google Scholar]
  3. Albers J. J., Wahl P., Hazzard W. R. Quantitative genetic studies of the human plasma Lp(a) lipoprotein. Biochem Genet. 1974 Jun;11(6):475–486. doi: 10.1007/BF00486079. [DOI] [PubMed] [Google Scholar]
  4. Albers J. J., Warnick G. R., Wiebe D., King P., Steiner P., Smith L., Breckenridge C., Chow A., Kuba K., Weidman S. Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein. Clin Chem. 1978 Jun;24(6):853–856. [PubMed] [Google Scholar]
  5. Allard C., Goulet C. Usefulness of a simple serum beta-lipoprotein assay: an epidemiological study of an active Montreal population. Can Med Assoc J. 1967 Nov 25;97(22):1321–1328. [PMC free article] [PubMed] [Google Scholar]
  6. Berg K. Further studies on the Lp system. Vox Sang. 1966 Jul-Aug;11(4):419–426. doi: 10.1111/j.1423-0410.1966.tb04238.x. [DOI] [PubMed] [Google Scholar]
  7. Bradley D. D., Wingerd J., Petitti D. B., Krauss R. M., Ramcharan S. Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. N Engl J Med. 1978 Jul 6;299(1):17–20. doi: 10.1056/NEJM197807062990104. [DOI] [PubMed] [Google Scholar]
  8. Brown D. F., Daudiss K. Hyperlipoproteinemia. Prevalence in a free-living population in Albany, New York. Circulation. 1973 Mar;47(3):558–566. doi: 10.1161/01.cir.47.3.558. [DOI] [PubMed] [Google Scholar]
  9. Carlson L. A., Ericsson M. Quantitative and qualitative serum lipoprotein analysis. Part 1. Studies in healthy men and women. Atherosclerosis. 1975 May-Jun;21(3):417–433. doi: 10.1016/0021-9150(75)90054-4. [DOI] [PubMed] [Google Scholar]
  10. Castelli W. P., Doyle J. T., Gordon T., Hames C. G., Hjortland M. C., Hulley S. B., Kagan A., Zukel W. J. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation. 1977 May;55(5):767–772. doi: 10.1161/01.cir.55.5.767. [DOI] [PubMed] [Google Scholar]
  11. Dahlén G., Berg K., Frick M. H. Lp(a) lipoprotein/pre-beta1-lipoprotein, serum lipids and atherosclerotic disease. Clin Genet. 1976 Jun;9(6):558–566. doi: 10.1111/j.1399-0004.1976.tb01613.x. [DOI] [PubMed] [Google Scholar]
  12. Dahlén G., Berg K., Frick M. H. Lp(a) lipoprotein/pre-beta1-lipoprotein, serum lipids and atherosclerotic disease. Clin Genet. 1976 Jun;9(6):558–566. doi: 10.1111/j.1399-0004.1976.tb01613.x. [DOI] [PubMed] [Google Scholar]
  13. EVALUATION of serum lipoprotein and cholesterol measurements as predictors of clinical complications of atherosclerosis; report of a cooperative study of lipoproteins and atherosclerosis. Circulation. 1956 Oct;14(4 Pt 2):691–742. [PubMed] [Google Scholar]
  14. Ellefson R. D., Elveback L. R., Hodgson P. A., Weidman W. H. Cholesterol and triglycerides in serum lipoproteins of young persons in Rochester, Minnesota. Mayo Clin Proc. 1978 May;53(5):307–320. [PubMed] [Google Scholar]
  15. Fredrickson D. S., Levy R. I., Lees R. S. Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med. 1967 Jan 5;276(1):34–contd. doi: 10.1056/NEJM196701052760107. [DOI] [PubMed] [Google Scholar]
  16. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502. [PubMed] [Google Scholar]
  17. Gibson T. C., Whorton E. B. The prevalence of hyperlipidemia in a natural community. J Chronic Dis. 1973 Apr;26(4):227–236. doi: 10.1016/0021-9681(73)90103-3. [DOI] [PubMed] [Google Scholar]
  18. Gordon T., Castelli W. P., Hjortland M. C., Kannel W. B., Dawber T. R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977 May;62(5):707–714. doi: 10.1016/0002-9343(77)90874-9. [DOI] [PubMed] [Google Scholar]
  19. Hewitt D., Jones G. J., Godin G. J., McComb K., Breckenridge W. C., Little J. A., Steiner G., Mishkel M. A., Baillie J. H., Martin R. H. Normative standards of plasma cholesterol and triglyceride concentrations in Canadians of working age. Can Med Assoc J. 1977 Nov 5;117(9):1020–1024. [PMC free article] [PubMed] [Google Scholar]
  20. Hewitt D., Jones G. J., Godin G. J., Wraight D., Breckenridge W. C., Little J. A., Steiner G., Mishkel M. A. Nature of the familial influence on plasma lipid levels. Atherosclerosis. 1979 Apr;32(4):381–396. doi: 10.1016/0021-9150(79)90005-4. [DOI] [PubMed] [Google Scholar]
  21. Hewitt D., Milner J., Breckenridge C., Little J. A., Kuksis A. A twin study on the heritability of lipoprotein fractions. Acta Genet Med Gemellol (Roma) 1976;25:150–153. doi: 10.1017/s0001566000014021. [DOI] [PubMed] [Google Scholar]
  22. Hewitt D., Milner J., Breckenridge C., Maguire G. Heritability of "sinking" pre-beta lipoprotein level: a twin study. Clin Genet. 1977 Mar;11(3):224–226. doi: 10.1111/j.1399-0004.1977.tb01304.x. [DOI] [PubMed] [Google Scholar]
  23. Ho W. K., Chan W. Y. Serum lipid and lipoprotein levels in normal Chinese. Clin Chim Acta. 1974 Dec 2;57(2):149–154. doi: 10.1016/0009-8981(74)90423-9. [DOI] [PubMed] [Google Scholar]
  24. Kannel W. B. Prospects for prevention of atherosclerosis in the young. Aust N Z J Med. 1976 Oct;6(5):410–419. doi: 10.1111/j.1445-5994.1976.tb03026.x. [DOI] [PubMed] [Google Scholar]
  25. LITTLE J. A., VAN DER FLIER R. W., SHANOFF H. M. Serum lipids and lipoproteins in healthy adult Canadian males. Can Med Assoc J. 1962 Jun 9;86:1045–1055. [PMC free article] [PubMed] [Google Scholar]
  26. Miller G. J., Miller N. E. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet. 1975 Jan 4;1(7897):16–19. doi: 10.1016/s0140-6736(75)92376-4. [DOI] [PubMed] [Google Scholar]
  27. Rhoads G. G., Gulbrandsen C. L., Kagan A. Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. N Engl J Med. 1976 Feb 5;294(6):293–298. doi: 10.1056/NEJM197602052940601. [DOI] [PubMed] [Google Scholar]
  28. Rifkind B. M., Tamir I., Heiss G., Wallace R. B., Tyroler H. A. Distribution of high density and other lipoproteins in selected LRC prevalence study populations: a brief survey. Lipids. 1979 Jan;14(1):105–112. doi: 10.1007/BF02533578. [DOI] [PubMed] [Google Scholar]
  29. Slack J. Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states. Lancet. 1969 Dec 27;2(7635):1380–1382. doi: 10.1016/s0140-6736(69)90930-1. [DOI] [PubMed] [Google Scholar]
  30. Stone N. J., Levy R. I., Fredrickson D. S., Verter J. Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. Circulation. 1974 Mar;49(3):476–488. doi: 10.1161/01.cir.49.3.476. [DOI] [PubMed] [Google Scholar]
  31. Utermann G., Vogelberg K. H., Steinmetz A., Schoenborn W., Pruin N., Jaeschke M., Hees M., Canzler H. Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III. Clin Genet. 1979 Jan;15(1):37–62. [PubMed] [Google Scholar]
  32. Wood P. D., Haskell W., Klein H., Lewis S., Stern M. P., Farquhar J. W. The distribution of plasma lipoproteins in middle-aged male runners. Metabolism. 1976 Nov;25(11):1249–1257. doi: 10.1016/s0026-0495(76)80008-x. [DOI] [PubMed] [Google Scholar]
  33. Wood P. D., Stern M. P., Silvers A., Reaven G. M., von der Groeben J. Prevalence of plasma lipoprotein abnormalities in a free-living population of the Central Valley, California. Circulation. 1972 Jan;45(1):114–126. doi: 10.1161/01.cir.45.1.114. [DOI] [PubMed] [Google Scholar]
  34. van der Steeg H. J., Pronk J. C. The effect of an oral contraceptive on serum lipoproteins and skinfold thickness in young women. Contraception. 1977 Jul;16(1):29–38. doi: 10.1016/0010-7824(77)90127-5. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES